Antimicrobial resistance Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting antimicrobial resistance clinical trials across 6 countries. Studies span Not Applicable, Phase 4. Top locations include Basel, Switzerland, Bologna, Bologna, Italy, Bologna, Italy. Updated daily from ClinicalTrials.gov.


Antimicrobial resistance Trials at a Glance

7 actively recruiting trials for antimicrobial resistance are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Basel, Bologna, and Bologna. Lead sponsors running antimicrobial resistance studies include Maria Espinosa Perez, Nantes University Hospital, and IRCCS Azienda Ospedaliero-Universitaria di Bologna.

Browse antimicrobial resistance trials by phase

About Antimicrobial resistance Clinical Trials

Looking for clinical trials for Antimicrobial resistance? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Antimicrobial resistance trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Antimicrobial resistance clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 4

Azithromycin for Child Survival in Niger II

Antimicrobial resistanceMortality
University of California, San Francisco3,300,000 enrolled1 locationNCT06358872
Recruiting
Not Applicable

Molecular Microbiology- Guided Antimicrobial Stewardship Versus Standard Stewardship in Hospitalized Patients

Antimicrobial resistanceInfectionAntimicrobial Stewardship Program+1 more
Maria Espinosa Perez250 enrolled1 locationNCT07684300
Recruiting

PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE

Antimicrobial Resistance (AMR)Gram-negative Infections
IRCCS Azienda Ospedaliero-Universitaria di Bologna60 enrolled2 locationsNCT06717594
Recruiting

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

Antimicrobial resistancePneumoniaMicrobiome+1 more
Shanghai General Hospital, China800 enrolled1 locationNCT06566898
Recruiting

A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.

Antimicrobial resistance
Nantes University Hospital1,600 enrolled2 locationsNCT07234331
Recruiting

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria

Antimicrobial Resistance (AMR)
University Hospital, Basel, Switzerland8,000 enrolled1 locationNCT05017766
Recruiting

PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections

Antimicrobial Resistance (AMR)Gram Negative Infection
University of Bologna120 enrolled11 locationsNCT06651047